Clinical protection study of pseudorabies vaccine (AUSKIPRA® GN bartha k61 strain) in piglets infected with new Chinese PRV variant

主页 知识 Clinical protection study of pseudorabies vaccine (AUSKIPRA® GN bartha k61 strain) in piglets infected with new Chinese PRV variant

Clinical protection study of pseudorabies vaccine (AUSKIPRA® GN bartha k61 strain) in piglets infected with new Chinese PRV variant

Since 2011, several pseudorabies (PR) outbreaks have damaged Chinese swine industry. The purpose of this experiment is to test the efficacy of pseudorabies vaccine AUSKIPRA® GN (HIPRA) against new pseudorabies virus variant (AH02).

关于该文章

出现于

APVS Congress, 2015

作者

Zeng, R.; Wang, J.; Torrents, D.; Martinez, C.; Pedrazuela, R.; Galé, I.

摘要

In this study AUSKIPRA® GN reconstituted with RED solvent reduce mortality, lung lesions and fever. Therefore, AUSKIPRA® GN can provide clinical protection in front of new PRV strains.

相关服务

相关产品

共享